Physician-executive and trusted advisor to senior leaders across healthcare innovation and global life sciences ecosystem.
Dr. Aparna Ahuja is a physician-executive and founder of AJA Life Sciences Advisory LLC, bringing over 20 years of global leadership across clinical research, medical affairs, healthcare innovation and diagnostics.
She advises senior executives, boards, and investors on clinical strategy, evidence generation, and decision-making for diagnostics, life sciences, and precision medicine. Her work focuses on helping organizations navigate complex inflection points—translating science into clear clinical direction, regulatory alignment, and commercially viable strategies.
Dr. Ahuja has held senior leadership roles at Abbott, Becton Dickinson, and T2 Biosystems, where she built and led global clinical and medical organizations, designed end-to-end evidence strategies, and supported regulatory approvals and global product adoption. Her experience spans in vitro diagnostics, molecular and genomic testing, and AI-enabled healthcare, with a track record of advancing innovation from development through commercialization and clinical adoption.
Dr. Ahuja’s early career has been focussed on population-scale clinical laboratory systems and clinical services, regulatory inspections (CAP, FDA, ISO, NABL, ANVISA), senior leadership in large-scale clinical laboratory networks (Agilus Diagnostics — formerly SRL Diagnostics — Fortis Global, Dr Lal PathLabs) in India and across APAC and EMEA regions. Deep knowledge of routine and advanced lab tests for cancer, cardiovascular disease, infectious disease, neurological diseases, genetic and prenatal, as well as technology enabled solutions to improve health outcomes.
Known for her ability to bring independent judgment, strategic clarity, and scientific rigor, she works directly with leadership teams on high-stakes decisions—whether shaping clinical programs, evaluating new technologies, or aligning clinical strategy with business objectives.
Dr. Ahuja is also an active contributor to global standards and professional organizations, including the Clinical and Laboratory Standards Institute (CLSI), College of American Pathologists (CAP), ISO 15189, the Association for Diagnostics & Laboratory Medicine (ADLM), and has led initiatives to advance diversity and access in clinical research.
Connect with Dr. AhujaHer perspective is shaped by careers spanning medical affairs, diagnostics, precision medicine, business development, portfolio strategy, evidence generation, and clinical research organizations.
Connecting deep clinical understanding with the commercial imperatives that drive adoption, market access, and sustainable growth across the life sciences value chain.
Translating rigorous clinical and real-world evidence into compelling value narratives that resonate with regulators, payers, providers, and strategic partners.
Bridging the gap between breakthrough innovation and scalable, real-world impact — ensuring that promising science reaches the patients and systems that need it most.
Grounded in four enduring principles that guide every engagement.
Focusing energy and attention on the decisions that matter most — the ones that shape trajectories, define positioning, and carry lasting consequence.
Making the complex understandable without oversimplifying. Distilling multifaceted challenges into clear, actionable frameworks for decision-makers.
Providing objective, trusted perspectives free from institutional bias. Independent advisory that leaders can rely on during high-stakes moments.
Aligning every recommendation with sustainable impact — ensuring that today's decisions create enduring value for organizations, patients, and the broader ecosystem.
While advisory in nature, she understands how strategy translates to real-world outcomes. Her experience includes:
Workflow optimization in clinical and laboratory environments, driving efficiency and quality across complex operational systems.
Real-world data (RWD), health economic modeling, and clinical evidence strategies that support regulatory, payer, and adoption pathways.
Aligning clinical evidence with commercial strategy to support product adoption, market access, and scalable growth across global markets.
Building frameworks that align innovation with measurable patient outcomes and economic value — bridging the gap between science and sustainable healthcare delivery.
Spanning established global organizations and emerging innovators across the life sciences landscape.
A published author and recognized voice in diagnostics, evidence-based healthcare, and medical affairs leadership.
Expert insights on the role of accurate diagnostics in respiratory illness prevention and public health preparedness.
September 2024Clinical and Laboratory Standards Institute guideline on specimen identification best practices.
March 2024Enterprise initiative expanding clinical trial accessibility through partnerships with historically underrepresented communities.
2024Peer-reviewed analysis on sepsis challenges in COVID-19, advancing the case for rapid diagnostic intervention.
January 2023Examining the role of rapid diagnostics in improving sepsis outcomes and combating antimicrobial resistance.
February 2022Multicenter clinical evaluation of nongel separator technology for therapeutic drug testing accuracy.
May 2020Authored article tracing the evolution of blood collection technology and its impact on diagnostic quality.
April 2019Peer-reviewed clinical study evaluating patient comfort and specimen integrity with novel blood collection technology.
2017Research publication on computational methods for diagnostic epitope design.
2014Case report on a rare co-occurrence of papillary serous adenocarcinoma and malignant Brenner’s tumor.
December 2011
Founded to provide senior-level, independent advisory at moments when leadership decisions carry significant weight.
"The most important decisions in life sciences require not just expertise but perspective, judgment, and the ability to integrate science with strategy and long-term value."
Mentoring physicians and emerging leaders navigating the transition from clinical practice to executive leadership in life sciences; first-time and underserved entrepreneurs.
Championing gender equity and supporting the advancement of women into senior leadership roles across the life sciences industry.
Supporting the development of the next generation of physician-executives — leaders who will bridge science, strategy, and healthcare delivery.
"I believe the future of healthcare will be shaped by leaders who can integrate science, strategy, and humanity — and I am committed to supporting those building that future."
— Dr. Aparna Ahuja
Whether you're navigating a complex strategic decision, exploring advisory support, or seeking a trusted perspective — let's start a conversation.
Or reach out directly at inquiry@ajalifesciencesadvisory.net